ReGenesys

Gaston Geenslaan 1
3001 Heverlee
BE
ReGenesys
Foundation date
17/10/2005
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
ReGenesys BV is a wholly-owned subsidiary of Athersys, Inc. (NASDAQ: ATHX), a biotechnology company in Cleveland, Ohio, U.S.A., that is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product initially for disease indications in the neurological, cardiovascular, inflammatory and immune areas. Athersys has several ongoing clinical trials to evaluate its MultiStem product candidate.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture
6 hours ago
Read more
-
Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology
1 day ago
Read more
-
Fat creates an ideal environment for metastatic breast tumors
1 day ago
Read more
Jobs
More jobs-
07/02/23
Brussels
Postdoctoral position in cancer immunology and the tumor immune microenvironment
Permanent
VIB -
-